Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26

Archives of Ophthalmology

Volumn 123, Issue 12, 2005, Pages 1639-1643

  Diener West, Marie ^a   Reynolds, Sandra M ^b   Agugliaro, Donna J ^b   Caldwell, Robert ^b   Cumming, Kristi ^b   Earle, John D ^b   Hawkins, Barbara S ^b   Hayman, James A ^b   Jaiyesimi, Ishmael ^b   Jampol, Lee M ^b   Kirkwood, John M ^b   Koh, Wui Jin ^b   Robertson, Dennis M ^b   Shaw, John M ^b   Straatsma, Bradley R ^b   Thoma, Jonni ^b  

^a Wilmer Clinical Trials and Biometry ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHOROID MELANOMA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; FOLLOW UP; HUMAN; LABORATORY TEST; LIVER METASTASIS; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME;

AGED; BRACHYTHERAPY; CHOROID NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; SURVIVORS; TIME FACTORS;

EID: 28944437419     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.123.12.1639     Document Type: Article

References (20)

1. Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991;98:383-390.
2. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation for large choroidal melanoma, II: initial mortality findings. COMS Report No. 10. Am J Ophthalmol. 1998;125:779-796.
3. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001;119:969-982.
4. Albert DM, Niffennegger AS, Willson JKV. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol. 1992;36:429-438.
5. Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651-4659.
6. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3. Control Clin Trials. 1993;14:362-373.
7. Collaborative Ocular Melanoma Study Group. Cause-specific mortality coding: methods in the Collaborative Ocular Melanoma Study. COMS Report No. 14. Control Clin Trials. 2001;22:248-262.
8. Duh EJ, Schachat AP, Albert DM, Patel SM. Long-term survival in a patient with uveal melanoma and liver metastasis. Arch Ophthalmol. 2004;122:285-286.
9. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS). COMS Report No. 15. Arch Ophthalmol. 2001;119:670-676.
10. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation for large choroidal melanoma, I: characteristics of patients enrolled and not enrolled. COMS Report No. 9. Am J Ophthalmol. 1998;125:767-778.
11. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: Characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol. 2001;119:951-965.
12. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS Report No. 24. Am J Ophthalmol. 2004;138:936-951.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Peto R, Peto J. Asymptotically efficient rank invariant procedures. J R Stat Soc A. 1972;135:185-206.
15. Collaborative Ocular Melanoma Study Group. Screening for metastasis from choroidal melanoma: the Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22:2438-2444.
16. Toivonen P, Makitie T, Kujala E, Kivela T. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci. 2004;45:1-6.
17. Pawlik TM, Sondak VK. Malignant melanoma: current state of primary and adjuvant treatment. Crit Rev Oncol Hematol. 2003;45:245-264.
18. Eskelin S, Pyrhonen S, Hahka-Kemppinen M, Tuomaala S, Kivela T. A prognostic model and staging for metastatic uveal melanoma. Cancer. 2003;97:465-475.
19. Alizadeh H, Howard K, Mellon J, Mayhew E, Rusciano D, Niederkorn JY. Reduction of liver metastasis of intraocular melanoma by interferon-beta gene transfer. Invest Ophthalmol Vis Sci. 2003;44:3042-3051.
20. Robertson DM. Changing concepts in the management of choroidal melanoma. Am J Ophthalmol. 2003;136:161-170.